1h Free Analyst Time
Patients with hypertension are generally treated with drugs that can reduce blood volume (reducing central venous pressure and cardiac output), reduce systemic vascular resistance, and reduce cardiac output by depressing heart rate and stroke volume. For instance, diuretic drugs decrease the blood volume by increasing urine output by the kidney. Similarly, vasodilator drugs dilate blood vessels through the relaxation of smooth muscle in blood vessels.
Speak directly to the analyst to clarify any post sales queries you may have.
Cardioinhibitory drugs depress cardiac function by decreasing heart rate, myocardial contractility, or both, which decreases cardiac output and arterial pressure. Hence, the availability of a wide range of therapeutics is offering specific treatment to the patients with hypertension and driving the growth of the global antihypertensive drugs market during the forecast period. The analysts have predicted that the antihypertensive drugs market will register a CAGR of over 2% by 2023.
Market Overview
Rising population with risk factors of hypertension
Some medical conditions can raise the risk of high blood pressure. The growing prevalence of diabetes increases the risk of development of hypertension. Hence, an increase in the number of people with these risk factors is expected to increase the number of people with hypertension. This, in turn, is expected to aid in the use of available drugs, which will drive the growth of the global antihypertensive drugs market during the forecast period.
Increasing generics popularity
Generic medicines contain the same active ingredient in the same quantity as a branded medicine. The development of generic drugs is simple and less time-taking. Therefore, the launch of generic drugs with lesser price than the innovator drugs is diluting and deceleration the market growth and is expected to hamper the growth of the market during our forecast period.
For the detailed list of factors that will drive and challenge the growth of the antihypertensive drugs market during the 2019-2023, view the full report.
Competitive Landscape
The market appears to be moderately fragmented and with the presence of several vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Table of Contents
PART 01: EXECUTIVE SUMMARYPART 06: PIPELINEPART 08: CUSTOMER LANDSCAPEPART 11: MARKET TRENDS
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 07: MARKET SEGMENTATION BY TYPE
PART 09: GEOGRAPHIC LANDSCAPE
PART 10: DRIVERS AND CHALLENGES
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
List of Exhibits
Executive Summary
Global Antihypertensive Drugs Market 2019-2023The analyst recognizes the following companies as the key players in the global antihypertensive drugs market: AstraZeneca, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer Inc..
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the development of modified release formulations.”
According to the report, one of the major drivers for this market is the increases funds for the research on hypertension.
Further, the report states that one of the major factors hindering the growth of this market is the drug failures in late- stage clinical trials.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- AstraZeneca
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.